过去一年中添加的文章，按日期排序
ABO-Mismatch Hematopoietic Stem Cell Transplantation with Pre-existing Red Cell Alloantibody Resembling a Case of Post-transplant Autoimmune Hemolytic …
A Sinha, A Nag, D Basu, SS Datta - Indian Journal of Hematology and …, 2024 - Springer
2 天前 - … Full antigen typing of the donor revealed that the stem cell donor was E … , which
were E-antigen positive. This evoked a delayed immune response, which normally takes around …
were E-antigen positive. This evoked a delayed immune response, which normally takes around …
DENV Peptides Delivered as Spherical Nucleic Acid Constructs Enhance Antigen Presentation and Immunogenicity in vitro and in vivo
J Zhao, J He, X Ding, Y Zhou, M Liu… - International Journal …, 2024 - Taylor & Francis
2 天前 - … Transcriptomic analysis highlighted genes linked to BMDCs maturation and
immune responses. In vivo studies immunization with SNA-TBB resulted in elevated antigen-…
immune responses. In vivo studies immunization with SNA-TBB resulted in elevated antigen-…
[HTML][HTML] Dendritic/antigen presenting cell mediated provision of T-cell receptor gamma delta (TCRγδ) expressing cells contributes to improving antileukemic reactions …
E Rackl, A Hartz, HA Rejeski, L Li, LK Klauer… - Molecular …, 2024 - Elsevier
2 天前 - … an MHC-independent immune response and could therefore qualify for immune
therapies. We examined the influence of dendritic cells(DC)/antigen presenting cell (APC) …
therapies. We examined the influence of dendritic cells(DC)/antigen presenting cell (APC) …
Chimeric antigen receptor T cell immunotherapy in multiple myeloma
A Oliver Caldés - tdx.cat
2 天前 - … CAR-T cell immunotherapy genetically modifies lymphocytes so that they recognize
a target antigen on the tumor cell and eliminate it. B-cell maturation antigen (BCMA) is a …
a target antigen on the tumor cell and eliminate it. B-cell maturation antigen (BCMA) is a …
[HTML][HTML] Predicting Regression of Barrett's Esophagus—Can All the King's Men Put It Together Again?
M Tobi, N Khoury, O Al-Subee, S Sethi, H Talwar… - Biomolecules, 2024 - mdpi.com
2 天前 - … This likely represents a reaction of the innate immune system, as this antigen is
usually released by Paneth cells, which are part of this system. The faint staining in the upper …
usually released by Paneth cells, which are part of this system. The faint staining in the upper …
[HTML][HTML] Immune Response after Vaccination against Tick-Borne Encephalitis Virus (TBEV) in Horses
D Kälin, A Becsek, H Stürmer, C Bachofen, D Siegrist… - Vaccines, 2024 - mdpi.com
2 天前 - … The objective of this study was to describe the immune response in horses after a
TBEV … antibodies (nAbs) are also the best marker for a protective humoral immune response …
TBEV … antibodies (nAbs) are also the best marker for a protective humoral immune response …
Using a Dual Immunoinformatics and Bioinformatics Approach to Design a Novel and Effective Multi-Epitope Vaccine against Human Torovirus Disease
2 天前 - … subunit vaccine (HToV-MEV) triggering diverse immune responses. We selected
non-allergenic, non-toxic, and antigenic epitopes from structural polyproteins, joined them with …
non-allergenic, non-toxic, and antigenic epitopes from structural polyproteins, joined them with …
Targeting Myeloid-Derived Suppressor Cells to Enhance Immune Checkpoint Inhibitor Therapy
HD Savardekar - 2024 - rave.ohiolink.edu
2 天前 - … Monoclonal antibodies (mAbs) and immune checkpoint inhibitors have provided …
and therapy response. TME modulation to enhance antitumor immune responses is a …
and therapy response. TME modulation to enhance antitumor immune responses is a …
Metabolic reprogramming of macrophages in cancer therapy
X Wang, S Zhang, D Xue, D Neculai, J Zhang - Trends in Endocrinology & …, 2024 - cell.com
2 天前 - … and present antigens, which is crucial for a robust immune response (… Antibodies
and small molecule compounds … on TAM-targeted antibodies and small molecules designed to …
and small molecule compounds … on TAM-targeted antibodies and small molecules designed to …
Intrathecal chemotherapy as treatment for chimeric antigen receptor T cell (CAR T) therapy associated neurotoxicity
SZ Bashey, SR Solomon, X Zhang, LE Morris… - Bone Marrow …, 2024 - nature.com
2 天前 - … Chimeric antigen receptor T cell (CAR T) therapy offers high remission rates for
patients with relapsed and refractory lymphomas. Immune effector cell-associated neurotoxicity …
patients with relapsed and refractory lymphomas. Immune effector cell-associated neurotoxicity …